Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis](https://www.mdpi.com/diseases/diseases-10-00085/article_deploy/html/images/diseases-10-00085-g001.png)
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921000744-gr2.jpg)
A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia](https://www.mdpi.com/biomolecules/biomolecules-11-00755/article_deploy/html/images/biomolecules-11-00755-g001.png)
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy](https://i1.rgstatic.net/publication/311339660_Cure_for_thalassemia_major_-_From_allogeneic_hematopoietic_stem_cell_transplantation_to_gene_therapy/links/59b7f5cd0f7e9bd4a7ff1be6/largepreview.png)
PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy
![IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia](https://www.mdpi.com/ijms/ijms-18-02778/article_deploy/html/images/ijms-18-02778-g001.png)
IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
![Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/572e4fa8-e370-41df-a173-6bc22c438ed6/ajh25909-fig-0001-m.jpg)
Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
![Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article](https://assets.cureus.com/uploads/figure/file/245562/lightbox_8acfee30f26a11eb908c39c985c12dca-fig.1.png)
Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article
![Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia - ScienceDirect Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222003613-fx1.jpg)
Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia - ScienceDirect
![Guidelines for the Management of Non-Transfusion Dependent Thalassaemias (2nd edition - 2017) by Thalassaemia International Federation (TIF) - Issuu Guidelines for the Management of Non-Transfusion Dependent Thalassaemias (2nd edition - 2017) by Thalassaemia International Federation (TIF) - Issuu](https://image.isu.pub/190625083856-41aa3feae0925fdc76612629c95e50f8/jpg/page_1.jpg)
Guidelines for the Management of Non-Transfusion Dependent Thalassaemias (2nd edition - 2017) by Thalassaemia International Federation (TIF) - Issuu
![Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu](https://image.isu.pub/220523125456-31254084c0fc681ef531a9580454bbd7/jpg/page_1.jpg)
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
![Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene](https://www.frontiersin.org/files/Articles/752278/fgeed-03-752278-HTML/image_m/fgeed-03-752278-g003.jpg)
Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
![Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley](https://onlinelibrary.wiley.com/cms/asset/a3ab599c-f810-44a4-8d26-916b998a40ec/ajh.25584.fp.png)